Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

PRESS: GlaxoSmithKline In Talks To Collaborate With Qualcomm - FT

20th Jan 2016 21:32

Read More

BROKER RATINGS SUMMARY: Exane BNP Upgrades Shire To Outperform

18th Jan 2016 09:42

Read More

BROKER RATINGS SUMMARY: JPMorgan Cuts Merlin To Underweight

14th Jan 2016 09:43

Read More

PRESS: Woodford Calls For Break-Up Of GlaxoSmithKline - BBC

8th Jan 2016 06:55

Read More

Dividends Calendar - Week Ahead

7th Jan 2016 16:06

Read More

GlaxoSmithKline's ViiV To Collaborate With Janssen On HIV-1 Treatment

7th Jan 2016 13:30

Read More

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

5th Jan 2016 09:43

Read More

Microsaic Systems Appoints Bevan Metcalf As Finance Director

21st Dec 2015 12:36

Read More

Glaxo Deal To Sell Ofatumumab Auto-Immune Indication Rights Completes

21st Dec 2015 11:42

Read More

GlaxoSmithKline's ViiV Venture To Buy Bristol-Myers HIV Assets

18th Dec 2015 07:14

Read More

GlaxoSmithKline Gets Positive Phase III Trial Results For Sirukumab

16th Dec 2015 14:06

Read More

BROKER RATINGS SUMMARY: Merrill Lynch Raises Glaxo To Buy From Neutral

9th Dec 2015 09:37

Read More

BROKER RATINGS SUMMARY: Nomura Cuts Kingfisher To Reduce From Neutral

7th Dec 2015 09:38

Read More

ReNeuron Group Appoints Ex-Glaxo Executive Owen To Board

4th Dec 2015 09:15

Read More

GlaxoSmithKline Gets European Marketing Authorisation For Nucala

3rd Dec 2015 06:20

Read More

GSK Says Nucala Available In US For Sub-group Of Patients With Severe Asthma

2nd Dec 2015 14:10

Read More

WINNERS & LOSERS SUMMARY: Greene King Stock In Good Spirits

2nd Dec 2015 10:31

Read More

BROKER RATINGS SUMMARY: JPMorgan, UBS And Barclays Like Ibstock

2nd Dec 2015 09:36

Read More

LONDON MARKET OPEN: Pharma Stocks Lead Gains; Sage Group Shares Down

2nd Dec 2015 08:29

Read More

GlaxoSmithKline Begins Dosing In Phase III Sirukumab Study

25th Nov 2015 11:30

Read More

FTSE 100 Latest
Value9,138.90
Change0.00